1. Home
  2. ACTG vs AURA Comparison

ACTG vs AURA Comparison

Compare ACTG & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acacia Research Corporation (Acacia Tech)

ACTG

Acacia Research Corporation (Acacia Tech)

HOLD

Current Price

$4.01

Market Cap

384.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.04

Market Cap

333.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACTG
AURA
Founded
1993
2007
Country
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
384.9M
333.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACTG
AURA
Price
$4.01
$5.04
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.20
AVG Volume (30 Days)
210.7K
206.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$127.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$81.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.70
$4.35
52 Week High
$4.41
$8.03

Technical Indicators

Market Signals
Indicator
ACTG
AURA
Relative Strength Index (RSI) 55.27 38.69
Support Level $3.93 $4.87
Resistance Level $4.10 $5.85
Average True Range (ATR) 0.15 0.36
MACD -0.01 -0.05
Stochastic Oscillator 48.39 14.06

Price Performance

Historical Comparison
ACTG
AURA

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: